N. Cabıoğlu Et Al. , "Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study," European Journal of Surgical Oncology , vol.51, no.6, 2025
Cabıoğlu, N. Et Al. 2025. Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study. European Journal of Surgical Oncology , vol.51, no.6 .
Cabıoğlu, N., KARANLIK, H., İğci, A., URAS, C., DÜLGEROĞLU, O., Karadeniz Çakmak, G., ... Sezer, A.(2025). Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study. European Journal of Surgical Oncology , vol.51, no.6.
Cabıoğlu, N. Et Al. "Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study," European Journal of Surgical Oncology , vol.51, no.6, 2025
Cabıoğlu, N. Et Al. "Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study." European Journal of Surgical Oncology , vol.51, no.6, 2025
Cabıoğlu, N. Et Al. (2025) . "Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study." European Journal of Surgical Oncology , vol.51, no.6.
@article{article, author={N. Cabıoğlu Et Al. }, title={Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study}, journal={European Journal of Surgical Oncology}, year=2025}